Loading...
Please wait, while we are loading the content...
Similar Documents
Adherencia a la prevención secundaria de la enfermedad coronaria
| Content Provider | Semantic Scholar |
|---|---|
| Author | Rossi, Emiliano De Brito Perman, Gastón Michelangelo, Hernán Alonzo, Claudia B. Brescacín, Laura Kopitowski, Karin Silvana Estrada, José Luis Navarro |
| Copyright Year | 2014 |
| Abstract | Medication adherence to secondary prevention for coronary artery disease. We compared the use of evidence-based secondary prevention drugs for coronary artery disease at hospital dis- chargeand�3�yearsoffollow-upinagroupofpatientsassociatedtoanintegratednetworkofhealthservices.�We� conductedaretrospectivegroupstudythatincluded�125�patientsunder�80�yearsofagewhowerehospitalized� foracutecoronarysyndrome.��McNemarstestwasusedtocomparevaluesatbaselineand�3�years.�Themean� ageofofparticipantswas�63.7�years�(SD�±�10.08)�and�65.6%�(95%�CI�56.6-73.9)�ofmalesex.�Theaverage� follow-uptimewas�2.94�years�(SD�±�0.25).�Theuseofsecondarypreventiondrugsforcoronaryheartdisease� decreasedat�3�yearsoffollow-up:�anti-platelet�97.6�to�88.0%�(p�=�0.012),�beta-blockers�94.4�to�84.8%�(p�=�0.021)� andstatins�83.7�to�91.2%�(p�=�0.035).�Patientsmedicatedwithacombinationofanti-platelet,�betablockersand� statinsshowedadecreasefrom�86.4�to�66.3%�(p�<�0.0001).�Itisnecessarytostudythecausesforthedecreased� adherencetolong-termcardio-protectivedrugs. |
| Starting Page | 99 |
| Ending Page | 103 |
| Page Count | 5 |
| File Format | PDF HTM / HTML |
| Volume Number | 74 |
| Alternate Webpage(s) | http://www.scielo.org.ar/pdf/medba/v74n2/v74n2a02.pdf |
| Alternate Webpage(s) | http://hiba.hospitalitaliano.org.ar/archivos/servicios_attachs/9417.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
